Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1353768

registered interest
date	08/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the JVCI recommendation to vaccinate 12 to 15 year olds against covid-19; and if he will make a statement.
tabling member constituency	Luton North
tabling member printed	Sarah Owen
uin	45279
answer	answer is ministerial correction date of answer 27/09/2021 answer text <p>In their advice of 3 September, the Joint Committee on Vaccination and Immunisation (JCVI) suggested that the Government may wish to seek further views on the wider societal and educational impacts of universal vaccination of 12 to 15 year olds from the United Kingdom Chief Medical Officers (CMOs), with representation from the JCVI in these subsequent discussions. Consequently, the Secretary of State for Health and Social Care, and the UK health ministers wrote to the CMOs to ask that they consider the vaccination of 12 to 15 year olds from a broader perspective, as suggested by the JCVI.</p><p>The UK CMOs have recommended the extension of the offer of a first dose of the Pfizer-BioNTech COVID-19 vaccine to all children and young people aged 12 to 15 years old on public health grounds. The Government has accepted this advice.<strong> </strong></p> answering member constituency Erewash answering member printed Maggie Throup question first answered 27/09/2021 10:33:54 answering member 4447 label Biography information for Maggie Throup previous answer version 21076 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4777 label Biography information for Sarah Owen

1353857

registered interest
date	08/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, across the UK, how many unused covid-19 vaccines have reached their expiry date in each of the last nine months.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	45234
answer	answer is ministerial correction date of answer 16/02/2022 answer text <p>Information on vaccine wastage prior to it entering the NHS England and NHS Improvement supply chain is not held in the format requested. Information on vaccine wastage within the NHS England and NHS Improvement supply chain is not held centrally. NHS England and NHS Improvement’s review of site deliveries, vaccination events, and site stocktakes would suggest that the number of vaccines deemed unusable at that point are within the bounds of planned expected waste.</p><p>Robust mitigations have been put in place throughout the vaccination programme to reduce wastage. Stock levels have been closely monitored at a regional, system and site level with deliveries adjusted accordingly. This includes keeping stock back in the supply chain and encouraging sites to reallocate stock at a local level, rather than draw from central stores. Vaccine deliveries have been carefully managed in line with site capacity, population density and available supply, to ensure that any vaccine being delivered would be used within as short a timeframe as possible.</p><p>Furthermore, following recent discussions with Pfizer and the Medicines and Healthcare products Regulatory Agency, on 17 January 2022 NHS England and NHS Improvement wrote to healthcare providers setting out that certain unpunctured and undamaged Pfizer COVID-19 vaccines have had their post thaw shelf-life extended from 31 days to 45 days. This proactive step will help to further mitigate the risk of vaccine wastage following the rapid scaling-up of the booster programme over Christmas. More information can be found at the following link:</p><p><a href="http://www.england.nhs.uk/coronavirus/publication/extending-the-post-thaw-expiry-date-of-specific-batches-of-comirnaty-30-microgram-dose-for-adults-and-adolescents/" target="_blank">www.england.nhs.uk/coronavirus/publication/extending-the-post-thaw-expiry-date-of-specific-batches-of-comirnaty-30-microgram-dose-for-adults-and-adolescents/</a></p> answering member constituency Erewash answering member printed Maggie Throup question first answered 16/02/2022 17:03:15 answering member 4447 label Biography information for Maggie Throup previous answer version 21092 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4603 label Biography information for Preet Kaur Gill

1353025

registered interest
date	06/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy to publish the data and evidential basis to support any deviation from the advice provided by the Joint Committee on Vaccination and Immunisation on administration of a covid-19 vaccine to children aged between 12 and 15.
tabling member constituency	Gateshead
tabling member printed	Ian Mearns
uin	43490
answer	answer is ministerial correction date of answer 28/09/2021 answer text <p>The United Kingdom Chief Medical Officers’ (CMOs) advice to offer universal vaccination to children and young people aged 12 to 15 years old and the data and evidential basis underpinning it was published on 13 September at the following link:</p><p><a href="https://www.gov.uk/government/publications/universal-vaccination-of-children-and-young-people-aged-12-to-15-years-against-covid-19" target="_blank">https://www.gov.uk/government/publications/universal-vaccination-of-children-and-young-people-aged-12-to-15-years-against-covid-19</a></p><p>The Joint Committee on Vaccination and Immunisation (JCVI) noted in its advice of 3 September that while the health benefits of vaccinating healthy 12 to 15 year olds outweighed the risks, the margin was too small to recommend vaccination on health grounds alone. The JCVI therefore suggested that the Government may wish to seek further views on the wider societal and educational impacts from the UK CMOs, with representation from the JCVI in these subsequent discussions. Noting the advice of the JCVI, Health Ministers then requested that the UK CMOs consider the matter, in line with JCVI advice. Accepting the JCVI’s advice, the UK CMOs considered the wider public health benefits of universal vaccination for this age group.</p><p>On 13 September, the Government accepted the advice of the UK CMOs to offer universal vaccination with a first dose of the Pfizer vaccine to children and young people aged 12 to 15 years old. This advice covers all those in this age group who were not already recommended for COVID-19 vaccination by existing advice from the JCVI.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 28/09/2021 12:57:05 answering member 4447 label Biography information for Maggie Throup previous answer version 19925 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4000 label Biography information for Ian Mearns

1351083

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria his Department will use to determine whether the temporary expansion of eligibility for flu vaccination to people aged over 50 should be made permanent.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	40612
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>Advice from the Joint Committee on Vaccination and Immunisation (JCVI) noted that it was advisable to continue the vaccination of the 50–64-year-old cohort because from the age of 50 years old, individuals are at a greater risk of being hospitalised as a result of COVID-19 and the result of coinfection of COVID-19 and flu is likely to be more severe. However, no decision has been made on whether the eligibility of this cohort will be made permanent.</p><p>The Department will continue to consider the advice of the JCVI in decisions on which flu cohorts are recommended for a flu vaccine in the future. The JCVI use the National Institute for Health and Care Excellence’s methodology and criteria to assess whether a vaccine programme can be considered cost effective or not.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/09/2021 15:02:32 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18931 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	429 label Biography information for Derek Twigg

1351282

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Quarantine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reason the Government is allowing travellers from the USA who have been double vaccinated against covid-19 to enter the UK without quarantining but not those double vaccinated travellers from Canada.
tabling member constituency	Tynemouth
tabling member printed	Sir Alan Campbell
uin	40617
answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>From 2 August, passengers that have been fully vaccinated with vaccines authorised by the European Medicines Agency in European countries and Food and Drug Administration in the United States of America have been able to travel to England without quarantine, or a day eight test. Decisions related to this policy are based on the latest risk assessment from the Joint Biosecurity Centre. We are working on expanding the number of people who can enter the United Kingdom more easily, including through engaging with international partners. We will provide an update in due course on how we will approach vaccinated individuals from other countries, including Canada.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 13/09/2021 16:43:42 answering member 4380 label Biography information for Jo Churchill previous answer version 18919 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	529 label Biography information for Sir Alan Campbell

1349570

registered interest
date	22/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the Government plans to publish the impact assessment on making covid-19 vaccination a condition of deployment in care homes; and what engagement is planned with the social care sector on that matter.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	38354
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The £100 million estimate set out in the Impact Statement refers to the midpoint of the potential cost of the policy; the number of staff leaving care homes and the impact on employers could be lower than this estimate. Given this uncertainty, we are continuing to monitor the uptake rate and the potential impact of the regulations on the ability of care homes to continue delivering the best quality care.</p><p> </p><p>The Government published operational guidance on 4 August 2021 to support providers to implement the policy. The Guidance provides information on good employment practice for care homes, including on the importance of following a fair procedure before dismissing.</p><p> </p><p>We are working with Skills for Care to ensure that resources such as guidance and best practice are available to support providers and local authorities with capacity and workforce planning, recruitment and well-being.</p><p> </p><p>To support providers with the implementation of the policy, the Advisory, Conciliation and Arbitration Service (ACAS) have published high-level advice on vaccination as a condition of deployment. ACAS are developing more detailed guidance to further support and share good practice across the sector.</p><p> </p><p>The full impact assessment on making COVID-19 vaccination a condition of deployment in care homes will be published as soon as possible.</p><p>The Department has worked closely with stakeholders throughout the development of this policy and will continue to do so throughout its implementation.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 38355 question first answered 08/09/2021 15:10:45 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18938 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4510 label Biography information for Helen Hayes

1349571

registered interest
date	22/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Statement of impact – The Health and Social Care Act 2008 (Regulated Activities) (Amendment) (Coronavirus) Regulations 2021 updated 19 July 2021 and the estimated of £100 million for making vaccination a condition of deployment in care homes, how that cost will be funded; and what (a) legal and (b) employment expertise will be made available to care home providers to implement that policy.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	38355
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The £100 million estimate set out in the Impact Statement refers to the midpoint of the potential cost of the policy; the number of staff leaving care homes and the impact on employers could be lower than this estimate. Given this uncertainty, we are continuing to monitor the uptake rate and the potential impact of the regulations on the ability of care homes to continue delivering the best quality care.</p><p> </p><p>The Government published operational guidance on 4 August 2021 to support providers to implement the policy. The Guidance provides information on good employment practice for care homes, including on the importance of following a fair procedure before dismissing.</p><p> </p><p>We are working with Skills for Care to ensure that resources such as guidance and best practice are available to support providers and local authorities with capacity and workforce planning, recruitment and well-being.</p><p> </p><p>To support providers with the implementation of the policy, the Advisory, Conciliation and Arbitration Service (ACAS) have published high-level advice on vaccination as a condition of deployment. ACAS are developing more detailed guidance to further support and share good practice across the sector.</p><p> </p><p>The full impact assessment on making COVID-19 vaccination a condition of deployment in care homes will be published as soon as possible.</p><p>The Department has worked closely with stakeholders throughout the development of this policy and will continue to do so throughout its implementation.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 38354 question first answered 08/09/2021 15:10:45 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18944 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4510 label Biography information for Helen Hayes

1348636

registered interest
date	20/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment the Government has made of the demographic breakdown of people who have been hospitalised with covid-19 after receiving (a) one and (b) two doses of a vaccine.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	36724
answer	answer is ministerial correction date of answer 15/09/2021 answer text <p>Public Health England publishes the age and sex breakdown of hospitalisations for COVID-19 for the most recent four week period on a weekly basis at the following link:</p><p><a href="https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fstatistics%2Fnational-flu-and-covid-19-surveillance-reports-2021-to-2022-season&amp;data=04%7C01%7Ccovid19surv%40phe.gov.uk%7Cd8a5d4ca5e2f4eec8d8208d94c3161e0%7Cee4e14994a354b2ead475f3cf9de8666%7C0%7C0%7C637624597245146774%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=BkHeLCF%2BjpJrbhFP464Z7rzY3nC%2BJubS5l4XJFMrOK8%3D&amp;reserved=0" target="_blank">https://www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2021-to-2022-season</a></p><p>The analysis is based on data from a sentinel network of acute National Health Service trusts contributing enhanced data.</p><p>PHE publishes technical briefings which provide the latest data regarding hospitalisations and deaths by variant, including the Delta variant, as well as data concerning those hospitalised with the Delta variant of COVID-19 who are vaccinated with one and both doses and unvaccinated. These data are retrospective and do not represent current hospitalisations. Data is available from 1 February 2021 at the following link:</p><p><a href="https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201" target="_blank">https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/09/2021 15:51:12 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18922 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4603 label Biography information for Preet Kaur Gill

1348754

registered interest
date	20/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether it is his policy to ensure that in any booster vaccine programme third doses of covid-19 vaccines are prioritised for people who are immunosuppressed in (a) Newcastle upon Tyne and (b) other areas with a number of cases.
tabling member constituency	Newcastle upon Tyne East
tabling member printed	Mr Nicholas Brown
uin	36530
answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) recognises that some individuals who are severely immunosuppressed due to underlying health conditions or medical treatment may not achieve the same full immune response to the initial two dose COVID-19 vaccination course as those who are not immunosuppressed. The committee has therefore advised on 1 September that as a precautionary measure those with severe immunosuppression at or around the time of their first or second dose of COVID-19 vaccination should receive a third dose. The aim is to raise the level of immunity in these individuals closer to the level of immunity as the non-immunosuppressed achieve from two doses in Newcastle upon Tyne and other areas.</p><p>The Government has accepted this advice, which will be applied at a national level. Severe immunosuppression at the time of vaccination is defined using guidance and timings outlined at the following link:</p><p><a href="https://www.gov.uk/government/publications/third-primary-covid-19-vaccine-dose-for-people-who-are-immunosuppressed-jcvi-advice/joint-committee-on-vaccination-and-immunisation-jcvi-advice-on-third-primary-dose-vaccination" target="_blank">https://www.gov.uk/government/publications/third-primary-covid-19-vaccine-dose-for-people-who-are-immunosuppressed-jcvi-advice/joint-committee-on-vaccination-and-immunisation-jcvi-advice-on-third-primary-dose-vaccination</a></p><p>The purpose of the separate potential booster programme is to maximise protection in those who are most vulnerable to serious COVID-19 ahead of the winter months. The JCVI published interim advice on a potential Covid-19 booster vaccination programme on 30 June 2021, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022</a></p><p>Final decisions on the timing and scope and cohort eligibility of any COVID-19 vaccine booster programme will be confirmed once the JCVI has provided their final advice.</p><p>It is expected that severely immunosuppressed individuals will become eligible for a booster dose as part of any routine booster programme from around six months after their third dose, pending further advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 16:33:45 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18935 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	523 label Biography information for Mr Nicholas Brown

1348823

registered interest
date	20/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many covid-19 vaccinations have been delivered through (a) community pharmacies and (b) each of the top ten community pharmacy contractors which have delivered the highest number of covid-19 vaccinations to date.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	36524
answer	answer is ministerial correction date of answer 20/10/2021 answer text <p>As at 14 September 2021, over 11.1 million people have received their COVID-19 vaccination at a community pharmacy. We are unable to provide data on the number of vaccinations delivered by individual community pharmacy contractors to protect the security of those sites.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 33279 question first answered 20/10/2021 16:53:34 answering member 4447 label Biography information for Maggie Throup previous answer version 18946 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	298 label Biography information for Steve McCabe